|
Use of recovery factor in nitrosamine analysis in drug product
|
|
2
|
181
|
July 22, 2025
|
|
Question about N-Nitroso nicardipine
|
|
4
|
578
|
July 21, 2025
|
|
Alignment between Duplex Sequencing and transgenic rodent mutation assay data in the assessment of in vivo NDMA-induced mutagenesis-Pub
|
|
0
|
119
|
July 21, 2025
|
|
Trientine NDSRI Method Development
|
|
1
|
199
|
July 20, 2025
|
|
Can anybody have scientific rationale about the non formation of N-nitroso-amlodipine
|
|
3
|
432
|
July 18, 2025
|
|
Lifetime Cumulative Dose and Less Than Lifetime Approach
|
|
3
|
520
|
July 16, 2025
|
|
NDMA production in the presence of formaldehyde: Competition between acid-catalyzed and formaldehyde-catalyzed reactions
|
|
7
|
358
|
July 16, 2025
|
|
Nitrosamines evaluation in transdermal patches
|
|
12
|
1996
|
July 16, 2025
|
|
Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cells -Pub
|
|
0
|
243
|
July 12, 2025
|
|
MEGLUMINE (Methylglucamine)
|
|
27
|
3179
|
July 10, 2025
|
|
Analytical Procedures and Validation_Specificity parameter requirment
|
|
9
|
464
|
July 9, 2025
|
|
Synthesis Attempts and Failure Report 🧐
|
|
21
|
1224
|
July 7, 2025
|
|
Addendum to ICH M7 on Risk Assessment and Control of N-Nitrosamine Impurities
|
|
8
|
1642
|
July 3, 2025
|
|
🇦🇷 Nitrosaminas en Fármacos. Academia Nacional de Farmacia y Bioquimica
|
|
0
|
163
|
July 1, 2025
|
|
🇨🇭 SwissMedic Nitrosamine impurities: Udpated requirements
|
|
1
|
409
|
July 1, 2025
|
|
NDMA handling - safety measures
|
|
6
|
284
|
July 1, 2025
|
|
🚨 FDA deadline update
|
|
14
|
1117
|
August 7, 2025
|
|
Excipient Nitrosamine Risk Assessment Tool
|
|
0
|
266
|
June 30, 2025
|
|
CMO Nitrosamine Risk Assessment
|
|
7
|
398
|
June 27, 2025
|
|
A greener method for analysis of nitrosamines utilising GC-NPD
|
|
1
|
65
|
June 27, 2025
|
|
Nitrosamines in Carbamazepine?
|
|
5
|
891
|
June 27, 2025
|
|
Criterios de aceptación
|
|
2
|
89
|
June 26, 2025
|
|
Deriving safe limits for N-nitroso-bisoprolol by error-corrected next-generation sequencing (ecNGS) and benchmark dose (BMD) analysis, integrated with QM modeling and CYP-docking analysis
|
|
10
|
481
|
June 26, 2025
|
|
Limits more than one Nitrosamine?
|
|
44
|
2746
|
June 26, 2025
|
|
Quantifier and Qualifier Ion in mass spec
|
|
6
|
193
|
June 26, 2025
|
|
👨💻 Highly sensitive and robust LC-MS/MS method for determination of up to 15 small molecule nitrosamine in pharmaceutical drug substances
|
|
0
|
340
|
June 25, 2025
|
|
👨💻 Quantification of Nitrite and Nitrate in Colloidal Silicon Dioxide by IC
|
|
0
|
204
|
June 25, 2025
|
|
Analytical Method Development Strategy for Controlling Two New Nitrosamine Drug Substance Related Impurities (NDSRIs) in a Pharmaceutical Drug Product for Treatment of a Rare Disease -Pub
|
|
0
|
77
|
June 25, 2025
|
|
N-Nitroso Phenylephrine and N-Nitroso Phenylephrone
|
|
1
|
156
|
June 25, 2025
|
|
"Ribolaris" clinical trial has been partially suspended due to nitrosamine impurities in ribociclib batches
|
|
2
|
439
|
June 24, 2025
|